Search research articles
Contact Us
Filters
Showing results (211-220 of 324) with videos related to
Page
of 33
Sort By:
BMC Medicine
|
August 5, 2017
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study
Swe Swe Thit, Ne Myo Aung, Zaw Win Htet, et al.
AIDS Research and Therapy
|
October 30, 2008
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
Jintanat Ananworanich, Pope Kosalaraksa, Umaporn Siangphoe, et al.
AIDS Research and Human Retroviruses
|
October 4, 2013
Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients
Anchalee Avihingsanon, Stephen J Kerr, Baralee Punyawudho, et al.
European Journal of Immunology
|
November 7, 2012
The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection
Nabila Seddiki, Chansavath Phetsouphanh, Sanjay Swaminathan, et al.
Plos Pathogens
|
August 26, 2016
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission
Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
European Journal of Immunology
|
January 31, 2009
Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease
Nabila Seddiki, Sarah C Sasson, Brigitte Santner-Nanan, et al.
AIDS (London, England)
|
August 24, 2011
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
Kersten K Koelsch, Christoph Boesecke, Kristin McBride, et al.
AIDS (London, England)
|
March 3, 2006
A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1
Anthony D Kelleher, Rebekah L Puls, Mark Bebbington, et al.
Acta Crystallographica. Section F, Structural Biology Communications
|
October 7, 2016
Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity
Gwen E Owens, Danielle M New, Alejandra I Olvera, et al.
Molecular Therapy. Nucleic Acids
|
December 13, 2023
Dendritic amphiphilic siRNA: Selective albumin binding, <i>in vivo</i> efficacy, and low toxicity
Hassan H Fakih, Qi Tang, Ashley Summers, et al.
Page
of 33
Search research articles
Search
Showing results (211-220 of 324) with videos related to
Sort By:
Page
of 33
BMC Medicine
|
August 5, 2017
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study
Swe Swe Thit, Ne Myo Aung, Zaw Win Htet, et al.
AIDS Research and Therapy
|
October 30, 2008
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
Jintanat Ananworanich, Pope Kosalaraksa, Umaporn Siangphoe, et al.
AIDS Research and Human Retroviruses
|
October 4, 2013
Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients
Anchalee Avihingsanon, Stephen J Kerr, Baralee Punyawudho, et al.
European Journal of Immunology
|
November 7, 2012
The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection
Nabila Seddiki, Chansavath Phetsouphanh, Sanjay Swaminathan, et al.
Plos Pathogens
|
August 26, 2016
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission
Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
European Journal of Immunology
|
January 31, 2009
Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease
Nabila Seddiki, Sarah C Sasson, Brigitte Santner-Nanan, et al.
AIDS (London, England)
|
August 24, 2011
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
Kersten K Koelsch, Christoph Boesecke, Kristin McBride, et al.
AIDS (London, England)
|
March 3, 2006
A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1
Anthony D Kelleher, Rebekah L Puls, Mark Bebbington, et al.
Acta Crystallographica. Section F, Structural Biology Communications
|
October 7, 2016
Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity
Gwen E Owens, Danielle M New, Alejandra I Olvera, et al.
Molecular Therapy. Nucleic Acids
|
December 13, 2023
Dendritic amphiphilic siRNA: Selective albumin binding, <i>in vivo</i> efficacy, and low toxicity
Hassan H Fakih, Qi Tang, Ashley Summers, et al.
Page
of 33